Taken together, these findings indicate that the cGAS-STING-IFN pathway plays a critical role in the onset and development of AD, and that treatments targeting this pathway can alleviate IFN-related neuroinflammation and delay the progression of AD to some extent [61]. This evidence concerns the gene CGAS and Alzheimer disease.